EP0886642A4 - - Google Patents

Info

Publication number
EP0886642A4
EP0886642A4 EP96902613A EP96902613A EP0886642A4 EP 0886642 A4 EP0886642 A4 EP 0886642A4 EP 96902613 A EP96902613 A EP 96902613A EP 96902613 A EP96902613 A EP 96902613A EP 0886642 A4 EP0886642 A4 EP 0886642A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96902613A
Other versions
EP0886642A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from US08/780,370 external-priority patent/US5962268A/en
Publication of EP0886642A1 publication Critical patent/EP0886642A1/en
Publication of EP0886642A4 publication Critical patent/EP0886642A4/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
EP96902613A 1996-01-11 1996-01-11 Immune cell cytokine Withdrawn EP0886642A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002242964A CA2242964A1 (en) 1996-01-11 1996-01-11 Immune cell cytokine
PCT/US1996/000205 WO1997025338A1 (en) 1996-01-11 1996-01-11 Immune cell cytokine
US08/780,370 US5962268A (en) 1996-01-11 1997-01-09 DNA encoding an immune cell cytokine

Publications (2)

Publication Number Publication Date
EP0886642A1 EP0886642A1 (en) 1998-12-30
EP0886642A4 true EP0886642A4 (US06373033-20020416-M00018.png) 1999-01-13

Family

ID=27170760

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96902613A Withdrawn EP0886642A1 (en) 1996-01-11 1996-01-11 Immune cell cytokine

Country Status (3)

Country Link
EP (1) EP0886642A1 (US06373033-20020416-M00018.png)
CA (1) CA2242964A1 (US06373033-20020416-M00018.png)
WO (1) WO1997025338A1 (US06373033-20020416-M00018.png)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939093A (en) * 1987-02-02 1990-07-03 Cetus Corporation Human IL-2 like polypeptides, DNA sequences and recombinant DNA molecules therefore and methods for the production and use thereof
US5441871A (en) * 1989-06-01 1995-08-15 Health Research, Inc. Monoclonal antibody reactive to human leukemia and lymphoma cells and methods of using same for diagnosis and treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
IRVINE K.D. ET AL.: "fringe, a boundary-specific signaling molecule, mediates interactions between dorsal and ventral cells during Drosophila wing development", CELL, vol. 79, 18 November 1994 (1994-11-18), pages 595 - 606, XP000674204 *
See also references of WO9725338A1 *

Also Published As

Publication number Publication date
CA2242964A1 (en) 1997-07-17
EP0886642A1 (en) 1998-12-30
WO1997025338A1 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
ITMI960328A0 (US06373033-20020416-M00018.png)
ITBS960095V0 (US06373033-20020416-M00018.png)
IN187335B (US06373033-20020416-M00018.png)
IN181470B (US06373033-20020416-M00018.png)
IN186636B (US06373033-20020416-M00018.png)
IN186845B (US06373033-20020416-M00018.png)
ITMI960686V0 (US06373033-20020416-M00018.png)
IN187703B (US06373033-20020416-M00018.png)
ECSDI960303S (US06373033-20020416-M00018.png)
ITGE960060A0 (US06373033-20020416-M00018.png)
ITMI960033A0 (US06373033-20020416-M00018.png)
ITMI960184A0 (US06373033-20020416-M00018.png)
ITMI960504A0 (US06373033-20020416-M00018.png)
ITMI960506A0 (US06373033-20020416-M00018.png)
ITMI960663A0 (US06373033-20020416-M00018.png)
CN3045888S (US06373033-20020416-M00018.png)
CN3046753S (US06373033-20020416-M00018.png)
CN3045208S (US06373033-20020416-M00018.png)
CN3044349S (US06373033-20020416-M00018.png)
CN3047746S (US06373033-20020416-M00018.png)
CN3044348S (US06373033-20020416-M00018.png)
CN3044347S (US06373033-20020416-M00018.png)
CN3045806S (US06373033-20020416-M00018.png)
CN3045853S (US06373033-20020416-M00018.png)
CN3045880S (US06373033-20020416-M00018.png)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980811

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19981130

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20041216